ResearcherHokkaido UniversityActive in the last 2 years
Yuta Takeuchi
Matched on ORCID iD 0000-0001-6969-5996. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 6
2023: 1 paper · 2024: 2 papers
Papers 3
- Exhaustion, rather than lack of infiltration and persistence, of CAR-T cells hampers the efficacy of CAR-T therapy in an orthotopic PDAC xenograft model. Co-author DOI 10.1016/j.biopha.2023.116052↗
- Prognostic value of combined psoas muscle mass and controlling nutritional status in patients with pancreatic ductal adenocarcinoma: a retrospective cohort stu… First author DOI 10.1186/s12893-024-02395-2↗
- Tumor Growth Suppression of Pancreatic Cancer Orthotopic Xenograft Model by CEA-Targeting CAR-T Cells. Co-author DOI 10.3390/cancers15030601↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Osamu Sato · 3 shared papers, 2023–2024 · strength 0.53
- Paper Prognostic value of combined psoas muscle mass and controlling nutritional status in patients with pancreatic ductal ad… DOI 10.1186/s12893-024-02395-2↗
- Paper Exhaustion, rather than lack of infiltration and persistence, of CAR-T cells hampers the efficacy of CAR-T therapy in a… DOI 10.1016/j.biopha.2023.116052↗
- Paper Tumor Growth Suppression of Pancreatic Cancer Orthotopic Xenograft Model by CEA-Targeting CAR-T Cells. DOI 10.3390/cancers15030601↗
- Satoshi Hirano · 3 shared papers, 2023–2024 · strength 0.53
- Paper Prognostic value of combined psoas muscle mass and controlling nutritional status in patients with pancreatic ductal ad… DOI 10.1186/s12893-024-02395-2↗
- Paper Exhaustion, rather than lack of infiltration and persistence, of CAR-T cells hampers the efficacy of CAR-T therapy in a… DOI 10.1016/j.biopha.2023.116052↗
- Paper Tumor Growth Suppression of Pancreatic Cancer Orthotopic Xenograft Model by CEA-Targeting CAR-T Cells. DOI 10.3390/cancers15030601↗
- Takahiro Tsuchikawa · 2 shared papers, 2023–2024 · strength 0.33
- Yuma Aoki · 1 shared paper, 2024 · strength 0.21
- Shota Kuwabara · 1 shared paper, 2024 · strength 0.21
- Toru Nakamura · 1 shared paper, 2023 · strength 0.14
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.